桂林澳林制药有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Cefmenoxime Hydrochloride
- Product Name
- 盐酸头孢甲肟
- Approval Number
- 国药准字H20060379
- Approval Date
- Jan 22, 2025
NMPA
Cefmenoxime Hydrochloride for Injection
- Product Name
- 雷特迈星
- Approval Number
- 国药准字H20103230
- Approval Date
- Apr 1, 2021
NMPA
Cefmenoxime Hydrochloride for Injection
- Product Name
- 雷特迈星
- Approval Number
- 国药准字H20060380
- Approval Date
- Apr 1, 2021
NMPA
Cefmenoxime Hydrochloride for Injection
- Product Name
- 雷特迈星
- Approval Number
- 国药准字H20103229
- Approval Date
- Apr 1, 2021
NMPA
Cefmenoxime Hydrochloride for Injection
- Product Name
- 雷特迈星
- Approval Number
- 国药准字H20060381
- Approval Date
- Apr 1, 2021
NMPA
Ranitidine Hydrochloride Capsules
- Product Name
- 盐酸雷尼替丁胶囊
- Approval Number
- 国药准字H45021358
- Approval Date
- Aug 9, 2015
NMPA
Berberine Hydrochloride Tablets
- Product Name
- 盐酸小檗碱片
- Approval Number
- 国药准字H45021359
- Approval Date
- May 31, 2003
NMPA
Clinical Trials
No trials found
News
No news found